Tandem Diabetes Care (TNDM) Total Non-Current Liabilities (2013 - 2026)

Tandem Diabetes Care (TNDM) has 14 years of Total Non-Current Liabilities data on file, last reported at $970.6 million in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 33.0% year-over-year to $970.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $970.6 million (up 33.0% YoY) and the FY2025 annual result came in at $676.2 million, up 0.6% from the prior year.
• Total Non-Current Liabilities advanced to $970.6 million in Q1 2026, from $676.2 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $970.6 million in Q1 2026 to a low of $560.4 million in Q1 2022.
• A 5-year average of $656.9 million and a median of $665.5 million in 2024 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities jumped 35.84% — and 2023, when it dropped 0.15%.
• Tracing TNDM's Total Non-Current Liabilities over 5 years: stood at $588.9 million in 2022, then advanced by 3.1% to $607.2 million in 2023, then gained by 10.7% to $672.2 million in 2024, then increased by 0.6% to $676.2 million in 2025, then jumped by 43.53% to $970.6 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $970.6 million (Q1 2026), $676.2 million (Q4 2025), and $689.3 million (Q3 2025), per Business Quant data.